Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$6.81 - $9.71 $583,617 - $832,147
-85,700 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$7.45 - $12.32 $140,805 - $232,848
-18,900 Reduced 18.07%
85,700 $746,000
Q4 2020

Feb 16, 2021

SELL
$10.34 - $13.77 $26,884 - $35,802
-2,600 Reduced 2.43%
104,600 $1.14 Million
Q3 2020

Nov 04, 2020

BUY
$11.73 - $16.25 $273,309 - $378,625
23,300 Added 27.77%
107,200 $1.28 Million
Q2 2020

Jul 31, 2020

BUY
$13.68 - $20.46 $359,784 - $538,098
26,300 Added 45.66%
83,900 $1.35 Million
Q1 2020

May 08, 2020

BUY
$14.83 - $26.72 $854,208 - $1.54 Million
57,600 New
57,600 $894,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.